首页> 外文期刊>生物医学研究杂志(英文版) >Legal protection of the rights of clinical trial subjects in China
【24h】

Legal protection of the rights of clinical trial subjects in China

机译:中国临床试验受试者权利的法律保护

获取原文
获取原文并翻译 | 示例
       

摘要

Subjects in clinical trials,either patients with the target disease or healthy volunteers,inevitably run a risk of injury or even death.To protect human subjects'rights to life and health,the Declaration of Helsinki has been developed as"a statement of ethical principles for medical research involving human subjects"^([1])Though widely regarded as a milestone in human research ethics,it is not a law or regulation,and is unable to effectively protect human subjects'rights.In

著录项

  • 来源
    《生物医学研究杂志(英文版)》 |2018年第2期|77-80|共4页
  • 作者单位

    School of Humanities and Social Sciences, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    School of Humanities and Social Sciences, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    School of Humanities and Social Sciences, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    School of Humanities and Social Sciences, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 中国;
  • 关键词

  • 入库时间 2022-08-19 03:47:46
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号